Cannula related suppurative thrombophlebitis in the burned patient

Burns

Volumn 26, Issue 2, 2000, Pages 200-204

  Gillespie, P ^a,b   Siddiqui, H ^a   Clarke, J ^a  

^a QUEEN MARY S HOSPITAL   (United Kingdom)

^b STOKE MANDEVILLE HOSPITAL   (United Kingdom)

Author keywords

Burns; Diabetes; Sepsis; Suppurative thrombophlebitis

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; INSULIN;

ABSCESS; ADULT; ARTICLE; BURN; CANNULA; CANNULATION; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; INTRAVENOUS CATHETER; KLEBSIELLA PNEUMONIAE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHLEBOTOMY; SAPHENOUS VEIN; SEPSIS; THROMBOPHLEBITIS; VEIN SURGERY;

ADULT; ANTI-BACTERIAL AGENTS; BURNS; CATHETERIZATION, PERIPHERAL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; SAPHENOUS VEIN; SUPPURATION; THROMBOPHLEBITIS; WOUND HEALING;

EID: 0033958333     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-4179(99)00110-2     Document Type: Article

References (18)

1. Pruitt BA, McManus AT. The changing epidemiology of infection in burns patients. World J Surg 1992;16:57-67.
2. Pruitt BA, McManus AT, Kim SH, Treat RC. Diagnosis and treatment of cannula-related intravenous sepsis in burn patients. Ann Surg 1980;191:546-54.
3. Stein JM, Pruitt BA. Suppurative thrombophlebitis: a lethal iatrogenic disease. N Engl J Med 1970;282:1452-5.
4. Foley FD. The burn autopsy. Am J Clin Pathol 1969;152:1.
5. Park SM, Zachmann GC, Holliday WL, Fryburg DA, Edlich RF, Himel HN. Noninsulin-dependent diabetes mellitus: diagnostic and therapeutic challenges in the severely burned patient - a case report. Burns 1994;20:273-5.
6. Grant-Theule DA. Peridontal disease, diabetes, and immune response: a review. J W Soc Periodontol 1996;44:69-77.
7. McMahon MM, Bistrian BR. Host defenses and susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin North Am 1995;9:1-9.
8. Pruitt BA, Stein JM, Foley FD, Moncrief JA, O'Neill JA. Intravenous therapy in burn patients: suppurative thrombophlebitis and other life-threatening complications. Arch Surg 1970;100:399-404.
9. Elliott TSJ, Faroqui MH. Infections and intravascular devices. Br J Hosp Med 1992;48:496-503.
10. The European Working Party on Control of Hospital Infections, Nystrom B, Larsen SO, Dankert J, et al. Bacteraemia in surgical patients with intravenous devices: a European multicentre incidence study. J Hosp Infect 1983;4:338-49.
11. Herndon DN. Total burn care. Philadelphia: Saunders, 1996.
12. Franceschi D, Gerding RL, Phillips G, Fratianne RB. Risk factors associated with intravascular catheter infections in burned patients: a prospective, randomised study. J Trauma 1989;29:811-6.
13. Brook I, Frazier EH. Aerobic and anaerobic microbiology of superficial suppurative thrombophlebitis. Arch Surg 1996;13:95-7.
14. Andes DR, Urban AW, Acher CW, Maki DG. Septic thrombosis of the basilic, axillary, and subclavian veins caused by a peripherally inserted central venous catheter. Am J Med 1998;105:446-50.
15. Pearson ML. Guidelines for prevention of intravascular device related infections. Infect Control Hosp Epidemiol 1996;17:473.
16. Glynn AA, Ward V, Wilson J, Charlett A, Cookson B, Taylor L, et al. Hospital acquired infection: surveillance, policies, and practice. London: Public Health Laboratory Service, 1997.
17. Ruddy M, Kibbler CC. Removing intravascular lines at 72 h allows need for antibiotics to be reassessed. Br Med J 1998;316:1825-6.
18. Smallman L, Burdon DW, Alexander-Williams J. The effect of skin preparation and care on the incidence of superficial thrombophlebitis. Br J Surg 1980;67:861-2.